Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. (NASDAQ: DH) is a leading provider of healthcare commercial intelligence, specializing in delivering comprehensive data and analytics on healthcare providers and their activities. The company’s suite of solutions offers clients access to the most accurate and detailed information available, covering over 8,100 hospitals and Integrated Delivery Networks (IDNs), 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 Accountable Care Organizations (ACOs) and Health Information Exchanges (HIEs), 197,000 physician groups, 1.3 million physicians, and 750 Canadian hospitals.
Definitive Healthcare's robust data set helps organizations in the healthcare sector optimize everything from product development to go-to-market planning, and sales and marketing execution. Backed by Spectrum Equity, the company is committed to transforming data, analytics, and expertise into actionable healthcare commercial intelligence.
The company continually invests in enhancing its product offerings and expanding its data coverage. Recent achievements include a 14% year-over-year revenue growth in the third quarter, reaching $65.3 million. Additionally, Definitive Healthcare has forged strategic partnerships, such as the recent collaboration with VML Health to streamline engagement between pharmaceutical companies and Key Opinion Leaders (KOLs), leveraging the Monocl ExpertInsight platform.
Definitive Healthcare’s competitive edge lies in its ability to provide unparalleled insights into the healthcare provider market, which equips its clients with the necessary tools to identify and capitalize on new opportunities. The company’s platform supports clients in uncovering the right markets, opportunities, and individuals, thereby shaping the future of healthcare. With the majority of its revenue derived from the United States, Definitive Healthcare continues to be a pivotal player in the healthcare data analytics industry.
For more information, visit www.definitivehc.com.
Definitive Healthcare (Nasdaq: DH) reported a 60% increase in its Atlas Prescription Claims and significant growth in Atlas All-Payor Claims. This expansion enhances data for healthcare providers to improve patient outcomes, particularly in areas like rare diseases and oncology, with nearly 20% increases in these sectors. CEO Robert Musslewhite emphasized the value of the expanded dataset for driving commercial success, refining methodologies, and increasing patient cohort accuracy. The updated Atlas Dataset equips clients with comprehensive insights into patient care, provider behavior, and market trends.
Definitive Healthcare Corp. (Nasdaq: DH) announced its participation in the 25th Annual Needham Growth Conference. CEO Robert Musslewhite and CFO Rick Booth will present on January 11, 2023, at 11:00 a.m. ET. Interested parties can access the live webcast via the Definitive Healthcare investor relations website.
The company is recognized for its healthcare commercial intelligence, using data and analytics to assist clients in navigating market opportunities effectively.
Definitive Healthcare (Nasdaq: DH) has been recognized as one of the Top Places to Work in Massachusetts for the sixth consecutive year by The Boston Globe. The award is based on surveys of employee satisfaction, assessing factors like leadership and workplace culture. CEO Robert Musslewhite highlighted the company’s commitment to an inclusive culture and employee development. Additionally, Definitive Healthcare was named a Top Workplace in the United States by Energage. The company actively promotes diversity and engages in community support through its DefinitiveCares initiative.
Definitive Healthcare Corp. (Nasdaq: DH) has appointed Jon Maack as President effective November 3, 2022. Maack, who brings extensive experience in healthcare SaaS, will oversee product management, engineering, corporate strategy, and M&A, reporting to CEO Robert Musslewhite. Maack previously served as Chief Strategy Officer at athenahealth and held senior roles at Optum and Bain & Company. He expressed excitement about joining Definitive Healthcare, emphasizing the untapped potential in the healthcare commercial intelligence market as they aim to enhance tools for their customer base of over 3,000.
Definitive Healthcare Corp. (Nasdaq: DH) reported a 33% year-over-year revenue growth to $57.4 million for Q3 2022. The net loss narrowed to ($6.4) million from ($21.0) million in Q3 2021, representing 11% of revenue. Adjusted net income rose to $8.9 million with adjusted EBITDA at $16.4 million, or 29% of revenue. The company continues to gain traction with new customers and product launches, including Passport Express. For Q4 2022, it expects revenue between $58-59 million, a 26% increase year-over-year.
Definitive Healthcare Corp. (Nasdaq: DH) will release its third-quarter financial results for the period ending September 30, 2022, on November 3, 2022, after market close. A conference call and webcast to discuss these results will take place at 5:00 PM ET. Investors can access a live audio webcast on the company’s Investor Relations website. A replay will be available until November 17, 2022. Definitive Healthcare specializes in healthcare commercial intelligence, helping clients navigate market opportunities through its SaaS platform.
Definitive Healthcare (Nasdaq: DH) announced its commitment to the UN Global Compact, the largest corporate sustainability initiative globally, aimed at aligning operations with ten principles covering human rights, labor, environment, and anti-corruption.
CEO Robert Musslewhite emphasized the company's dedication to community betterment and transparency in sustainability efforts. The company also focuses on diversity, equity, and inclusion, enhancing hiring processes and engaging employees in community service through its DefinitiveCares program, while minimizing its environmental impact.
Definitive Healthcare announces a significant change in its Board of Directors, with Sastry Chilukuri joining as a member on September 30, 2022, while Randy Winn departs. Chilukuri, co-CEO of Medidata, brings over 22 years of experience in healthcare technology, expected to enhance the company's leadership in the life sciences sector. CEO Robert Musslewhite expressed optimism about Chilukuri’s contributions. Winn played a vital role in expanding the client base to over 3,000 and supporting the company through its recent IPO.
Definitive Healthcare Corp. (Nasdaq: DH) announced participation in two key conferences: the 2022 Baird Global Healthcare Conference in New York and the Goldman Sachs Communacopia + Technology Conference in San Francisco. CEO Robert Musslewhite will present on September 13, 2022, at 12:15 PM ET, while Executive Chairman Jason Krantz and CFO Rick Booth will present on September 14, 2022, at 5:15 PM PT (8:15 PM ET). Both presentations will be webcasted live, and replays will be accessible for a limited time on the investor relations website.
Definitive Healthcare (Nasdaq: DH) reported a 37% year-over-year revenue growth in Q2 2022, reaching $54.5 million. The net loss improved to ($9.6) million, representing 18% of revenue, compared to 38% in the previous year. Adjusted net income rose to $8.9 million, with an adjusted EBITDA of $16.3 million, or 30% of revenue. Cash flow from operations stood at $15.5 million or 28% of revenue. For Q3 2022, the company expects revenue between $56.0 – $57.0 million.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
What services does Definitive Healthcare Corp. provide?
How does Definitive Healthcare’s data benefit its clients?
What is the geographic focus of Definitive Healthcare’s revenue?
Who backs Definitive Healthcare Corp.?
What recent financial achievement has Definitive Healthcare reported?
What recent partnerships has Definitive Healthcare formed?
What types of healthcare providers are included in Definitive Healthcare’s data?
How does Definitive Healthcare stay competitive in the market?
What is the Monocl ExpertInsight platform used for?
Where can I find more information about Definitive Healthcare?
